TuisGLPG • NASDAQ
add
Galapagos NV - ADR
Vorige sluiting
$26,90
Dagwisseling
$27,24 - $27,58
Jaarwisseling
$24,16 - $42,46
Markkapitalisasie
1,84 mjd USD
Gemiddelde volume
276,26 k
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 59,85 m | -50,14% |
Bedryfskoste | 21,09 m | 112,58% |
Netto inkomste | -50,43 m | -295,24% |
Netto winsgrens | -84,26 | -491,54% |
Wins per aandeel | -0,74 | -289,74% |
EBITDA | -48,48 m | -86,02% |
Effektiewe belastingkoers | 1,16% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,34 mjd | -12,41% |
Totale bates | 4,17 mjd | -6,27% |
Totale aanspreeklikheid | 1,31 mjd | -28,43% |
Totale ekwiteit | 2,86 mjd | — |
Uitstaande aandele | 65,94 m | — |
Prys om te bespreek | 0,62 | — |
Opbrengs op bates | -3,21% | — |
Opbrengs op kapitaal | -4,69% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -50,43 m | -295,24% |
Kontant van bedrywe | -71,79 m | 39,58% |
Kontant van beleggings | 56,56 m | -69,02% |
Kontant van finansiering | -1,09 m | 47,41% |
Netto kontantverandering | -16,80 m | -127,39% |
Beskikbare kontantvloei | -66,59 m | 24,78% |
Meer oor
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Gestig
1999
Webwerf
Werknemers
683
